Bulletin of Experimental Biology and Medicine

, Volume 164, Issue 5, pp 609–611 | Cite as

Compounds of IL-6 Receptor Complex during Acute Lung Injury

  • D. A. Chepurnova
  • E. V. Samoilova
  • A. A. Anisimov
  • A. D. Verin
  • A. A. Korotaeva

Soluble receptor of IL-6 (sIL-6R) and antagonist of the receptor complex, soluble glycoprotein 130 (sgp130) mediate opposite effects during inflammation. We measured the levels of these cytokines and their ratio in rat blood on the model of acute lung injury. The injury was modeled by the intratracheal administration of LPS. The levels of sgp130 and sIL-6R increased during the inflammatory process in the injured lungs. The sgp130/sIL-6R ratio increased or decreased depending on the intensity of the inflammatory process. sgp130/sIL-6R ratio might reflect the intensity of inflammation during lung injury.

Key Words

inflammation soluble receptor of IL-6 sgp130 acute lung injury 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Simbirtsev AS. Oytokines in the pathogenesis of infectious and noninfectious human diseases. Med. Akad. Zh. 2013;(3):18-41. Russian.Google Scholar
  2. 2.
    Gonzales JN, Lucas R, Verin AD. The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches. Austin J. Vasc. Med. 2015;2(1):pii: 1009.Google Scholar
  3. 3.
    Han S, Mallampalli RK. The acute respiratory distress syndrome: from mechanism to translation. J. Immunol. 2015;194(3):855-860.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 2015;16(5):448-457.CrossRefPubMedGoogle Scholar
  5. 5.
    Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 2001;268(1):160-167.CrossRefPubMedGoogle Scholar
  6. 6.
    Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim. Biophys. Acta. 2002;1592(3):323-343.CrossRefPubMedGoogle Scholar
  7. 7.
    Liu H, Yu X, Yu S, Kou J. Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Int. Immunopharmacol. 2015;29(2):937-946.CrossRefPubMedGoogle Scholar
  8. 8.
    Liu F, Li W, Pauluhn J, Trübel H, Wang C. Lipopolysaccharide-induced acute lung injury in rats: comparative assessment of intratracheal instillation and aerosol inhalation. Toxicology. 2013;304:158-166.CrossRefPubMedGoogle Scholar
  9. 9.
    Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2008;295(3):L379-L399.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond). 2012;122(4):143-159.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • D. A. Chepurnova
    • 1
  • E. V. Samoilova
    • 1
  • A. A. Anisimov
    • 1
  • A. D. Verin
    • 2
  • A. A. Korotaeva
    • 1
  1. 1.National Medical Research Center of СardiologyMinistry of Healthcare of the Russian FederationMoscowRussia
  2. 2.Augusta UniversityAugustaUSA

Personalised recommendations